Advanced
loginLogin My account Interest product Order status Cart
 
Support
   
 
  Choose your location
 
   
 
Integrated Solutions & Services
 
100% Guarantee_July
 
ISO
 
Home > Support > Publications
  Publications
  Publication Search
  Total : 36125 publications.
   New Feature : Get publication update automatically by subscribing a free reader RSS Feed
Catalog # Product Name Authors Journal Name Article Title
H00000673-M02 BRAF monoclonal antibody (M02), clone 3D2 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00001398-B01P CRK purified MaxPab mouse polyclonal antibody (B01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00001399-D01P CRKL purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005295-M01 PIK3R1 monoclonal antibody (M01), clone 3A10 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005170-B01P PDPK1 purified MaxPab mouse polyclonal antibody (B01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005335-M01 PLCG1 monoclonal antibody (M01), clone 2A2 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00000891-D01P CCNB1 purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00002534-D01P FYN purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
PAB12647 KDR polyclonal antibody Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
PAB18088 YWHAZ polyclonal antibody Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00003954-M03 LETM1 monoclonal antibody (M03), clone 6F7 Shin JY, Chung YS, Kang B, Jiang HL, Yu DY, Han K, Chae C, Moon JH, Jang G, Cho MH Cancer Gene Ther. 2013 Feb 8. doi: 10.1038/cgt.2013.6. Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.
H00025855-M01 BRMS1 monoclonal antibody (M01), clone 2D4-2G11 Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR Cancer Res. 2013 Feb 15;73(4):1308-17. doi: 10.1158/0008-5472.CAN-12-2489. Epub 2012 Dec 26. BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300.
H00003021-M01 H3F3B monoclonal antibody (M01), clone 2D7-H1 Orsi GA, Algazeery A, Meyer RE, Capri M, Sapey-Triomphe LM, Horard B, Gruffat H, Couble P, Ait-Ahmed O, Loppin B PLoS Genet. 2013 Feb;9(2):e1003285. doi: 10.1371/journal.pgen.1003285. Epub 2013 Feb 7. Drosophila Yemanuclein and HIRA Cooperate for De Novo Assembly of H3.3-Containing Nucleosomes in the Male Pronucleus.
KA1334 MTT Cell Proliferation Assay Kit Kats A, Bage T, Georgsson P, Jonsson J, Quezada HC, Gustafsson A, Jansson L, Lindberg C, Nasstrom K, Yucel-Lindberg T FASEB J. 2013 Feb 27. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
H00010544-P01 PROCR (Human) Recombinant Protein (P01) Fink K, Busch HJ, Bourgeois N, Schwarz M, Wolf D, Zirlik A, Peter K, Bode C, von Zur Muhlen C PLoS One. 2013;8(2):e53103. doi: 10.1371/journal.pone.0053103. Epub 2013 Feb 7. Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?
H00009759-P01 HDAC4 (Human) Recombinant Protein (P01) Isaacs JT, Antony L, Dalrymple SL, Brennen WN, Gerber S, Hammers H, Wissing M, Kachhap S, Luo J, Xing L, Bjork P, Olsson A, Bjork A, Leanderson T Cancer Res. 2013 Feb 15;73(4):1386-99. doi: 10.1158/0008-5472.CAN-12-2730. Epub 2012 Nov 13. Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment.
H00007178-M01 TPT1 monoclonal antibody (M01), clone 3C7 Chen K, Chen S, Huang C, Cheng H, Zhou R Biol Cell. 2013 Feb 6. doi: 10.1111/boc.201200080. TCTP increases stability of hypoxia-inducible factor 1? by interaction with and degradation of the tumor suppressor VHL.
H00029978-M03 UBQLN2 monoclonal antibody (M03), clone 5F5 Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K Neuropathol Appl Neurobiol. 2013 Feb 20. doi: 10.1111/nan.12036. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
H00003169-M01 FOXA1 monoclonal antibody (M01), clone 2D7 Kobayashi T, Iwaya K, Moriya T, Yamasaki T, Tsuda H, Yamamoto J, Matsubara O BMC Clin Pathol. 2013 Feb 6;13:5. doi: 10.1186/1472-6890-13-5. A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.
H00002810-M01 SFN monoclonal antibody (M01), clone 3C3 Sousa MM, Zub KA, Aas PA, Hanssen-Bauer A, Demirovic A, Sarno A, Tian E, Liabakk NB, Slupphaug G PLoS One. 2013;8(2):e55493. doi: 10.1371/journal.pone.0055493. Epub 2013 Feb 6. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
< Prev12345678910Next >
Facebook Linkedin YouTube RSS
 
 
Terms & Conditions   |   Privacy Policy   |   Copyright and Trademark   
© 2013 Abnova Corporation. All rights reserved.
     
    If you have a question or comment, please select the topic you would like to contact.

Your message has been sent successfully!